Treatment
Medication clinical trials
We’re tracking 7,450 recruiting studies that include Medication, each written for real people, not researchers, below.
Recruiting studies
- NCT07627347Recruiting
Anlotinib and Bemocizumab for Early Esophageal Cancer
This study tests two drugs (anlotinib and bemocizumab) given before surgery to shrink esophageal squamous cell carcinoma (a type of throat cancer). The goal is to see if this combination helps patients have better outcomes and fewer side effects.
Guangzhou, GuangdongAges 18–70 - NCT06398977Recruiting
Dapagliflozin to protect kidney function in dialysis patients
This trial tests whether a diabetes drug called dapagliflozin can help people on peritoneal dialysis keep their remaining kidney function longer. It is for patients who started dialysis recently and still make urine.
Chengdu, SichuanAges 18–75 - NCT05728476Recruiting
Compare eye surgery plus peeling versus anti-VEGF injections
This trial compares a minimally invasive eye procedure (vitrectomy with peeling) versus anti-VEGF injections to treat new diabetic macular edema in people who have not had treatment yet. It looks at which option improves vision and eye swelling for people with diabetes.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT07314801Enrolling by invitation
Financial impact of cancer in young adults
This study looks at how cancer treatment affects your finances and your recovery, especially for young adults. It involves a phone interview and some questionnaires to understand your experience.
Göttingen, Lower SaxonyAges 18–50 - NCT06398873Recruiting
Dupilumab and nasal lining in chronic sinusitis with polyps
This study tests whether dupilumab, a medication given as an injection, helps improve the lining of the nose in people with chronic sinus inflammation and nasal polyps. If you have nasal polyps and are about to start dupilumab, or if you have sinusitis without polyps, you may be eligible to join.
Vienna, AustriaAges 18–99 - NCT06823700Recruiting
Study of SQ-Kyrin device for leaky mitral valve from heart failure
This trial tests a new device (SQ-Kyrin) to fix a leaky mitral valve without open-heart surgery. It is for people with heart failure whose valve leak causes symptoms, and who are not good candidates for traditional surgery.
Valladolid, ValladolidAges 18 years+ - NCT06833827Recruiting
Clot removal vs clot-busting drugs for severe lung clots
This study compares two ways to treat a large blood clot in the lungs that is causing life-threatening symptoms. One method uses a device to remove the clot, the other uses medicine to dissolve it.
Leiden, South HollandAges 18 years+ - NCT07693881Recruiting
Preventing EBV reactivation with rituximab after stem cell transplant in children
This trial tests whether adding a drug called rituximab to the standard transplant plan can help prevent Epstein-Barr virus (EBV) from reactivating in children receiving a half-matched stem cell transplant. It may help reduce a common viral complication after transplant.
GuangzhouAges Up to 18 years - NCT06221670RecruitingPhase 2
Toripalimab after surgery for high-risk early lung cancer
This trial tests whether giving a drug called Toripalimab after surgery can help prevent early-stage non-squamous non-small cell lung cancer from coming back. It is for people whose tumors have high-risk features and PD-L1 levels of at least 1%.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT06230471RecruitingPhase 2
Pembrolizumab plus lenvatinib or chemo for advanced bile duct cancer
This study tests whether adding another drug (lenvatinib or chemotherapy) to the immunotherapy drug pembrolizumab works better than pembrolizumab alone for advanced bile duct or gallbladder cancer that has not been treated before. It aims to find a more effective first treatment option.
Beijing, Beijing MunicipalityAges 18–80 - NCT06104215RecruitingEarly Phase 1
BGT007H cells for advanced digestive cancer
This trial tests a new cell therapy called BGT007H for people with advanced digestive tract cancers (esophagus, stomach, pancreas, or colon) that have not responded to or stopped working after at least two prior treatments. The goal is to see if this therapy can help shrink tumors or slow the disease.
Xuzhou, JiangsuAges 18–70 - NCT07304076Recruiting
JHG002 Injection for Chronic Low Back Pain
This study tests if JHG002 injections (made from human placenta) are safe and effective for treating chronic low back pain. It may help people who have had low back pain for at least 6 months and rate their pain as a 5 or higher on a 0–10 scale.
Seoul, Gangdong-guAges 19–70 - NCT06437886Enrolling by invitation
Comparing high-dose vs. lower-dose opioid anesthesia for heart surgery
This trial compares two types of anesthesia during heart surgery: one that uses high doses of strong painkillers (opioids) and one that uses less opioids. The goal is to see which approach is safer and helps patients recover better.
BeijingAges 45–70 - NCT06339268Recruiting
Brain and body training to prevent confusion after lung surgery
This study tests whether special physical and brain exercises before and after lung surgery can help older adults (ages 60+) avoid confusion or memory problems. Participants will use a tablet or phone to follow the program.
BelgradeAges 60 years+ - NCT02171845Recruiting
Study of how the body controls DNA “jumping genes” before birth
This study looks at how the body stops “jumping genes” (transposons) during fetal development, specifically in male fetuses. Families may be able to participate if the fetus is obtained from a planned pregnancy termination and meets the timing and screening requirements.
DijonAges 2 months–9 months - NCT02798731Recruiting
Testing blood vessel function after a heart transplant
This trial measures how well tiny blood vessels in the heart are working in people who have had a heart transplant. It may help doctors understand transplant-related circulation problems and guide future care.
SeoulAges 18–85 - NCT07458334Recruiting
Skincare benefits of a kaempferol face mask
This trial tests a face mask containing kaempferol, a natural plant compound, to see if it improves skin health. It may be a good option if you are a woman looking for a new skincare product.
Kaohsiung CityAges 25–60 - NCT07634705Recruiting
Digital app to help manage depression in primary care
This study tests a smartphone app called Moodivate that helps treat depression through your regular doctor's office using video visits. It's designed for people with mild-to-moderate depression who want a flexible, technology-based treatment option.
Charleston, South CarolinaAges 18 years+ - NCT06731348Enrolling by invitationPhase 4
Pain pill options after pelvic surgery
This trial compares two different amounts of opioid pain pills after surgery for women with pelvic floor problems. The goal is to see if a lower dose still provides good pain relief and keeps patients satisfied.
Bethesda, MarylandAges 18 years+ - NCT07084818Enrolling by invitation
Helping Pessary Users Manage Their Care at Home
This study tests a program to help women with pelvic organ prolapse who live in rural areas take better care of their pessary at home. You may join if you use a pessary for prolapse, have stage 2 or higher prolapse, and are not dealing with active infections or certain other conditions.
Lebanon, New HampshireAges 18 years+ - NCT07056140Recruiting
Simulation training for epidural pain relief placement
This trial tests if simulation-based training helps anesthesia residents learn to place epidural catheters for pain relief. It may be right for you if you are a resident with little experience placing epidurals.
PadovaAges 18 years+ - NCT01266915Recruiting
Cutaneous lupus skin disease registry study
This study builds a registry (a protected medical record) of people with cutaneous lupus and/or systemic lupus that affects the skin. It gathers skin exam information and may include a skin biopsy and blood tests to better understand these conditions.
Dallas, TexasAges 18 years+ - NCT02797457Recruiting
Evaluating outcomes of donated hand and forearm transplants
This trial looks at whether donated (allograft) hand and forearm transplants are worth it compared with artificial devices, including cost and real-world results. It is meant for adults with amputations of both forearms who may be medically and psychologically able to receive the transplant.
BerckAges 18–60 - NCT05913180RecruitingPhase 2
Vitamin C to prevent urine infections after gynecologic surgery
This Phase 2 study tests whether taking vitamin C can lower the chance of getting a urinary tract infection (UTI) after planned gynecologic surgery. It may help people who want to reduce post-surgery infection risk.
MoscowAges 18–80
Common questions
- Are there clinical trials studying Medication?
- Yes. Clin2 currently lists 7,450 recruiting studies that include Medication, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Medication trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Medication an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Medication or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.